FeesSafety
Pluang+

Circuit Mind launches AVE, an AI tool to verify PCB designs and prevent costly errors before production.

Others
28 Oct 2026, 19:00 WIB
Globe Newswire
View Source
Bullish
Circuit Mind launches AVE, an AI tool to verify PCB designs and prevent costly errors before production.

Circuit Mind has introduced AVE (Agentic Verification Engine), an AI-powered application that verifies printed circuit board (PCB) schematics against datasheets and internal design rules to catch errors early and avoid expensive respins. AVE complements Circuit Mind's existing ACE tool, enhancing the electronic design intelligence platform to speed up hardware design and improve accuracy. The platform uses a combination of AI and physics-based algorithms to ensure reliable design decisions, helping engineers reduce design time dramatically. Following a $25 million funding round, Circuit Mind plans to expand its platform to cover more stages of the electronics design lifecycle.

Circuit Mind's launch of AVE, an AI-powered design verification tool, is presented here with a snapshot of the Technology sector on Pluang. Of 150 priced US technology stocks, 55 advanced and 88 declined. Notable movers include IREN at USD 28.37 with a 3.39% gain and a typical hold time of 30 days, CORZ at USD 14.73 up 3.29% with 100% buy order activity, and CLS at USD 284.52 rising 3.06%. This data is as of Oct 28, 2026 19:12 WIB.

More News

Circuit Mind raises $25M to speed up AI-driven electronic design and verification

Circuit Mind raises $25M to speed up AI-driven electronic design and verification

Circuit Mind secured $25 million in funding, including an $18.5 million Series A led by Norwest, to expand its AI platform that automates and optimizes electronic circuit board design. The platform helps companies reduce design time by up to 90%, cut...

Others
Bullish
14 minutes ago
Alvotech to report Q3 2026 financial results on Nov 11 with live webcast presentation.

Alvotech to report Q3 2026 financial results on Nov 11 with live webcast presentation.

Alvotech, a global biotech company specializing in biosimilars, will release its financial results for the first nine months of 2026 on November 11 after U.S. market close. A live webcast presentation is scheduled for November 12 at noon, where manag...

Company Fundamentals
Neutral
1 hour ago
Sampo to release Q3 2026 results on Nov 4 with a live investor call.

Sampo to release Q3 2026 results on Nov 4 with a live investor call.

Sampo Oyj will publish its financial results for the first nine months of 2026 on November 4, 2026, at around 8:30 AM. Alongside the report, supplementary presentation materials will be available on their website. An investor conference call will be ...

Company Fundamentals
Neutral
1 hour ago
Alvotech to release Q3 2026 financial results on November 11 with a webcast Q&A on November 12

Alvotech to release Q3 2026 financial results on November 11 with a webcast Q&A on November 12

Alvotech, a global biotech company specializing in biosimilars, announced it will report its financial results for the nine months and third quarter ending September 30, 2026, on November 11 after U.S. market close. The company will host a webcast wi...

Company Fundamentals
Neutral
1 hour ago
Stella-Jones executives to present at RBC Capital Markets 2026 Global Industrials Conference

Stella-Jones executives to present at RBC Capital Markets 2026 Global Industrials Conference

Stella-Jones Inc. announced that its CEO Eric Vachon and CFO Silvana Travaglini will participate in the RBC Capital Markets 2026 Global Industrials Conference in New York on November 16, 2026. The company will hold meetings with institutional investo...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App